Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-31
2006-10-31
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S394000, C548S178000, C548S310100
Reexamination Certificate
active
07129258
ABSTRACT:
This invention provides estrogen receptor modulators of formula I, having the structurewhereinR1, R2, R2a, R3, R3a, and R4, and X as defined in the specification, or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 5919808 (1999-07-01), Petrie et al.
patent: 5948776 (1999-09-01), Petrie et al.
patent: 6331562 (2001-12-01), Bhagwat et al.
patent: 6518301 (2003-02-01), Barlaam et al.
patent: 2002/0183310 (2002-12-01), Miller et al.
patent: WO 97/09348 (1997-03-01), None
patent: WO 98/17267 (1998-04-01), None
patent: WO 99/07847 (1999-02-01), None
patent: WO 00/01716 (2000-01-01), None
patent: WO 00/19994 (2000-04-01), None
patent: WO 00/31112 (2000-06-01), None
patent: WO 00/39120 (2000-07-01), None
patent: WO 00/55137 (2000-09-01), None
patent: WO 00/59897 (2000-10-01), None
patent: WO 00/61230 (2000-10-01), None
patent: WO 00/62765 (2000-10-01), None
patent: WO 00/76529 (2000-12-01), None
patent: WO 01/82923 (2001-11-01), None
patent: WO 02/46168 (2002-06-01), None
patent: WO 02/051821 (2002-07-01), None
G.G.J.M. Kuiper et al., Endocrinology, vol. 138, No. 3, pp. 863-870, 1997.
M.F. Stevens et al., J. Med. Chem., May 1994, 1689-1695, 37(11).
E. Von Angerer et al., J. Med. Chem., Jan. 1983, 113-116, 26(1).
E. Von Angerer et al., J. Med. Chem., Nov. 1984, 1439-1447, 27(11).
Matsuzaki, Sachiko et al., Fertility & Sterility, 73(6), 1219-1225 (2000).
Matsuzaki, Sachiko et al., Fertility & Sterility, 74(4), 753-759 (2000).
Matsuzaki, Sachiko et al., Fertility & Sterility, 75(6), 1198-1205 (2000).
U.S. Appl. No. 10/146,562, filed May 15, 2002, by C.P. Miller et al.
Harris et al., Evaluation of an Estrogen Receptor-β Agonist in Animal Models of Human Disease, Endocrinology, vol. 144, No. 10, 4241-4249, 2003.
Collini Michael D.
Gunawan Iwan
Malamas Michael S.
Manas Eric S.
McDevitt Robert E.
Milowsky Arnold S.
O'Connor Cozen
Saeed Kamal A.
Shiao Robert
Straher Michael P.
LandOfFree
Substituted benzoxazoles as estrogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzoxazoles as estrogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzoxazoles as estrogenic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3651112